Adolescent Idiopathic Scoliosis, Scoliosis Idiopathic
Conditions
Keywords
lung functions, vertebral derotation, chest intervention
Brief summary
This study was conducted to determine the physiological and mechanical effects of physical training post surgical correction of adolescent scoliosis using vertebral derotation.
Detailed description
Sixty patients from both sexes with idiopathic scoliosis underwent posterior correction (fusion). They were presented with idiopathic scoliosis for 6-12 month. Their mean Cobb's angle was measured in degrees and their mean angle of rotation was measured also in degrees. Before participation all the patients were examined clinically by a chest physician to exclude any cardio pulmonary or vascular disorders which may alter the pulmonary functions. All of them did not receive any physical therapy program prior to the operation. Patients were arranged randomly into two groups (1 and 2), each containing 30 patients. Group 1 (DRG) received posterior correction, vertebral derotation technique during posterior correction and pulmonary rehabilitation program while group 2 (NDRG) received posterior correction and the same rehabilitation program given to group 1.
Interventions
* Incentive spirometer (Mediciser): Used for breathing exercises. * Cycle ergometer ( Mijnhardt , St. Paul, MN): Used for lower limb exercise.
Sponsors
Study design
Intervention model description
The exercise group received vertebral derotation with posterior correction in addition to routine chest physiotherapy (group A). The Control group received only posterior correction with routine chest physiotherapy (group B).
Eligibility
Inclusion criteria
* Male patients suffering from adolescent idiopathic scoliosis. * Participant age ranged from 12- 18 years old. * All patients had the same medical care. * Participants have received a good explanation of the treatment and measurement device. * Treatment was conducted surgical intervention.
Exclusion criteria
* Instability of patient's medical condition. * Presence of any diseases that could affect the study results. * Participants having respiratory, cardiac, or neurological diseases that affect pulmonary functions.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| (FEV1 and MVV) were measured by using the spirometer Pulmonary functions testing | Five months | Each patient's weight in kilograms, and height in meters were recorded and entered the machine. An individual sat in a chair and inhaled deeply before closing their mouth tightly around the tube. Several exercises were carried out until the patient comprehended and was comfortable with the instruction. The patient inhaled deeply and exhaled as quickly as possible into the spirometer(Morgan Trans Flow Test Vicatest p2 (Kent, ME 87 ED, England). |
Countries
Egypt